Comments
Loading...

Poseida Therapeutics

PSTXNASDAQ
Logo brought to you by Benzinga Data
$9.44
-0.06-0.63%
At close: -
$9.41
-0.03-0.32%
After Hours: 7:38 PM EDT
Consensus Rating1
Overweight
Highest Price Target1
$24.00
Lowest Price Target1
$9.00
Consensus Price Target1
$14.40

Poseida Therapeutics (NASDAQ:PSTX) Stock, Analyst Ratings, Price Targets, Forecasts

Poseida Therapeutics Inc has a consensus price target of $14.4 based on the ratings of 7 analysts. The high is $24 issued by Cantor Fitzgerald on January 7, 2022. The low is $9 issued by HC Wainwright & Co. on November 26, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on November 26, 2024, November 15, 2024, and November 8, 2024, respectively. With an average price target of $16.33 between HC Wainwright & Co., there's an implied 73.57% upside for Poseida Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Jul
1
Aug
2
Oct
2
3
Nov
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Piper Sandler
Cantor Fitzgerald
HC Wainwright & Co.
Cantor Fitzgerald

1calculated from analyst ratings

Analyst Ratings for Poseida Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Poseida Therapeutics (PSTX) stock?

A

The latest price target for Poseida Therapeutics (NASDAQ:PSTX) was reported by BTIG on November 26, 2024. The analyst firm set a price target for $0.00 expecting PSTX to fall to within 12 months (a possible -100.00% downside). 13 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Poseida Therapeutics (PSTX)?

A

The latest analyst rating for Poseida Therapeutics (NASDAQ:PSTX) was provided by BTIG, and Poseida Therapeutics downgraded their neutral rating.

Q

When was the last upgrade for Poseida Therapeutics (PSTX)?

A

There is no last upgrade for Poseida Therapeutics

Q

When was the last downgrade for Poseida Therapeutics (PSTX)?

A

The last downgrade for Poseida Therapeutics Inc happened on November 26, 2024 when BTIG changed their price target from N/A to N/A for Poseida Therapeutics Inc.

Q

When is the next analyst rating going to be posted or updated for Poseida Therapeutics (PSTX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Poseida Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Poseida Therapeutics was filed on November 26, 2024 so you should expect the next rating to be made available sometime around November 26, 2025.

Q

Is the Analyst Rating Poseida Therapeutics (PSTX) correct?

A

While ratings are subjective and will change, the latest Poseida Therapeutics (PSTX) rating was a downgraded with a price target of $0.00 to $0.00. The current price Poseida Therapeutics (PSTX) is trading at is $9.41, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch